Key Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Key Financial's ARKG Position: Q3 2026 in Review
Key Financial held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2026 at 55 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.
Key Financial first reported a position in ARKG in Q2 2021 and has held it in 22 quarters since. The position peaked at $3K in Q3 2021. 260 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Key Financial held 55 shares of ARK Genomic Revolution ETF worth $2.98K as of Q3 2026.
- Key Financial left its ARK Genomic Revolution ETF share count unchanged in Q3 2026.
- ARK Genomic Revolution ETF made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1070 holding.
- Key Financial first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 22 quarters since.
- Key Financial's ARK Genomic Revolution ETF position peaked at $3K in Q3 2021.
- 260 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.